Back to LLY
Man Group plc LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
21
Latest value
$64.9M
Q3 2026
Peak value
$451.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $366.1M |
| Q4 2025 | $21.9M |
| Q4 2025 | $71.3M |
| Q4 2025 | $71.3M |
| Q1 2026 | $353M |
| Q1 2026 | $34.7M |
| Q1 2026 | $460K |
| Q1 2026 | $63.2M |
| Q1 2026 | $828K |
| Q1 2026 | $63.2M |
| Q1 2026 | $828K |
| Q2 2026 | $451.3M |
| Q2 2026 | $27.1M |
| Q2 2026 | $1.2M |
| Q2 2026 | $65.6M |
| Q2 2026 | $1.2M |
| Q2 2026 | $65.6M |
| Q3 2026 | $445.9M |
| Q3 2026 | $6M |
| Q3 2026 | $64.9M |
| Q3 2026 | $64.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $64.9M | 56.1K | — | — |
| Q3 2026 | $64.9M | 56.1K | — | — |
| Q3 2026 | $6M | 5.2K | — | — |
| Q3 2026 | $445.9M | 385.4K | — | — |
| Q2 2026 | $65.6M | 54.7K | — | — |
| Q2 2026 | $1.2M | 1.0K | — | — |
| Q2 2026 | $65.6M | 54.7K | — | — |
| Q2 2026 | $1.2M | 1.0K | — | — |
| Q2 2026 | $27.1M | 22.6K | — | — |
| Q2 2026 | $451.3M | 376.2K | — | — |
| Q1 2026 | $828K | 900 | — | — |
| Q1 2026 | $63.2M | 68.7K | — | — |
| Q1 2026 | $828K | 900 | — | — |
| Q1 2026 | $63.2M | 68.7K | — | — |
| Q1 2026 | $460K | 500 | — | — |
| Q1 2026 | $34.7M | 37.7K | — | — |
| Q1 2026 | $353M | 383.8K | — | — |
| Q4 2025 | $71.3M | 66.3K | — | — |
| Q4 2025 | $71.3M | 66.3K | — | — |
| Q4 2025 | $21.9M | 20.4K | — | — |
| Q4 2025 | $366.1M | 340.7K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B